Growth
Dan Zanger: Leader
18 Hits · last calculated September 18, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 18 hits from US
Methodology & criteria
Zanger's real strategy (not the widely circulated 'Liquid High Beta' variant). He buys institutional market leaders: explosive earnings growth (≥ 50%), top relative strength, high-priced liquid stocks near their highs, market cap up to $10 billion — and only enters on a volume breakout (≥ 300% of average) out of a base. This screener delivers the leader watchlist; the breakout itself is discretionary. 70% technical, 30% fundamental, inspired by O'Neil's CAN SLIM.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Volatility | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FORM FormFactor Inc | 07/29 | +126 % | 85 % | Stage 2 | A 79 | 8 of 9 | 9.5 $ | Semiconductor Equipment & Materials | Uses AI | — | — | Technology | 111.50 $ | +156.0 % | +147.9 % | +251.1 % | −6.5 % | +24.3 % | 97 | 91 | 9.4 % | 8.6 % | 1.24 | 110.5 | 28.3 | 10.6 | 7.1 | 70.0 | 1.39 | 42.9 | 17.7 % | 46.2 % | 12.8 % | 6.8 % | 7.4 % | 0.04 | 84.3 % | +2.8 % | 5 | 0.0 % | 0.0 % | 12.3 | 98.8 % | 5.4 % | 3.7 (10) |
| ATEX Anterix Inc | 08/11 | +51 % | 61 % | Stage 2 | B 66 | 7 of 9 | 1.5 $ | Telecom Services | Neutral | — | Communication Services | 77.40 $ | +266.4 % | +339.9 % | +263.0 % | −8.1 % | +45.1 % | 97 | 85 | 8.3 % | 8.2 % | 0.84 | 17.7 | 0.0 | 203.2 | 6.3 | 100.2 | — | -12.4 | — | 100.0 % | 933.0 % | 43.3 % | -5.9 % | 0.02 | — | +7.8 % | 6 | 0.0 % | 0.0 % | 3.5 | 91.8 % | 13.3 % | 4.7 (3) | |
| AGX Argan Inc | — | +629 % | 76 % | Stage 2 | A 77 | 5 of 9 | 5.8 $ | Engineering & Construction | Uses AI | — | — | Industrials | 383.00 $ | +135.6 % | +141.6 % | +60.7 % | −4.8 % | +49.6 % | 96 | 86 | 7.0 % | 7.0 % | 0.57 | 33.8 | 16.6 | 4.9 | 11.2 | 10.6 | — | 23.2 | 15.6 % | 20.7 % | 15.1 % | 38.5 % | 10.0 % | — | 36.8 % | +8.1 % | 8 | 0.7 % | 15.8 % | 8.1 | 108.9 % | 7.8 % | 4.0 (2) |
| NWPX Northwest Pipe Company | 08/06 | +127 % | 40 % | Stage 2 | B 71 | 8 of 9 | 1.0 $ | Steel | – | — | — | Basic Materials | 103.00 $ | +121.8 % | +130.9 % | +98.8 % | −3.6 % | +7.8 % | 96 | 90 | 4.6 % | 4.4 % | 1.10 | 24.1 | 19.8 | 1.8 | 2.4 | 12.7 | 1.80 | 12.4 | 9.2 % | 20.9 % | 8.5 % | 10.7 % | 6.5 % | 0.25 | 63.7 % | +6.8 % | 5 | 0.0 % | 0.0 % | 9.1 | 87.9 % | 8.3 % | 4.0 (2) |
| SNEX Stonex Group Inc | 08/04 | +151 % | 47 % | Stage 2 | B 55 | 6 of 9 | 7.9 $ | Capital Markets | Neutral | — | Financial Services | 66.10 $ | +117.5 % | +77.2 % | +57.9 % | −3.3 % | +13.5 % | 95 | 87 | 6.0 % | 4.9 % | 0.64 | 17.7 | 9.8 | 0.1 | 2.9 | 1.5 | — | 10.6 | 0.5 % | 1.7 % | 0.3 % | 20.2 % | 1.2 % | 7.16 | 5.0 % | +32.5 % | 2 | 0.0 % | 0.0 % | 5.5 | 85.9 % | 4.7 % | 5.0 (2) | |
| MYRG MYR Group Inc | 07/29 | +84 % | 50 % | Stage 2 | B 68 | 9 of 9 | 4.5 $ | Engineering & Construction | Neutral | — | Industrials | 276.80 $ | +114.2 % | +120.8 % | +56.3 % | −0.9 % | +48.8 % | 95 | 86 | 5.2 % | 5.4 % | 1.31 | 30.3 | 20.0 | 1.1 | 6.1 | 23.0 | 3.41 | 14.1 | 6.4 % | 12.5 % | 4.1 % | 22.7 % | 8.5 % | 0.11 | 42.0 % | +8.8 % | 5 | 0.0 % | 0.0 % | 6.9 | 104.4 % | 5.3 % | 4.6 (5) | |
| ATRO Astronics Corporation | 08/05 | +154 % | 54 % | Stage 2 | B 64 | 6 of 9 | 3.2 $ | Aerospace & Defense | Neutral | — | Industrials | 64.90 $ | +91.0 % | +94.2 % | +103.0 % | −12.8 % | +54.9 % | 95 | 89 | 6.0 % | 5.8 % | 1.20 | — | 27.2 | 3.4 | — | 47.2 | 1.46 | 21.5 | 11.8 % | 32.3 % | 8.4 % | 21.2 % | 11.2 % | — | 21.6 % | +8.4 % | 4 | 0.0 % | 0.0 % | 7.9 | 101.1 % | 9.5 % | 3.3 (3) | |
| OSCR Oscar Health Inc | 08/05 | +84 % | 69 % | Stage 2 | B 64 | 7 of 9 | 9.2 $ | Healthcare Plans | Uses AI | — | — | Healthcare | 32.00 $ | +108.3 % | +97.3 % | +80.0 % | −5.6 % | -4.1 % | 94 | 87 | 5.6 % | 6.6 % | 2.37 | — | 588.2 | 0.6 | 6.1 | 2.1 | — | 0.0 | 15.2 % | 20.2 % | 3.6 % | -2.6 % | 4.5 % | 0.26 | 17.9 % | +27.5 % | 4 | 0.0 % | 0.0 % | 3.0 | 67.6 % | 6.5 % | 3.3 (7) |
| BHE Benchmark Electronics Inc | 07/29 | +95 % | 44 % | Stage 2 | B 62 | 8 of 9 | 2.7 $ | Electronic Components | Neutral | — | Technology | 74.60 $ | +113.2 % | +113.5 % | +92.3 % | −1.3 % | +15.3 % | 94 | 92 | 5.0 % | 4.8 % | 1.27 | 73.9 | 14.1 | 1.0 | 2.4 | 21.6 | 1.33 | 17.5 | 3.8 % | 10.3 % | 1.9 % | 3.1 % | 3.1 % | 0.28 | 52.3 % | +0.1 % | 4 | 0.9 % | 27.1 % | 8.1 | 107.4 % | 4.4 % | 4.0 (3) | |
| NESR National Energy Services Reunited Corp. | 08/19 | +252 % | 55 % | Stage 2 | B 69 | 7 of 9 | 3.3 $ | Oil & Gas Equipment & Services | Neutral | — | Energy | 32.50 $ | +60.1 % | +89.1 % | +208.3 % | −2.6 % | +33.2 % | 94 | 87 | 5.7 % | 5.1 % | 0.40 | 50.0 | 0.0 | 2.0 | 3.2 | 14.2 | — | 11.8 | 8.9 % | 13.3 % | 5.8 % | 6.7 % | 4.8 % | 0.31 | 51.7 % | +1.7 % | 7 | 0.0 % | 0.0 % | 5.0 | 85.2 % | 5.2 % | 4.3 (3) | |
| KALU Kaiser Aluminum Corporation | 07/22 | +64 % | 52 % | Stage 2 | B 68 | 7 of 9 | 2.6 $ | Aluminum | – | — | — | Basic Materials | 155.10 $ | +57.6 % | +61.9 % | +106.4 % | −6.9 % | +9.9 % | 93 | 90 | 4.5 % | 4.7 % | 1.60 | 17.3 | 27.7 | 0.6 | 3.0 | 23.6 | 1.17 | 7.2 | 8.8 % | 14.5 % | 5.5 % | 18.8 % | 7.8 % | 1.22 | 31.5 % | +11.5 % | 3 | 2.1 % | 24.3 % | 6.7 | 100.8 % | 6.8 % | 3.7 (3) |
| SEI Solaris Energy Infrastructure, Inc | 07/22 | +327 % | 78 % | Stage 2 | B 69 | 5 of 9 | 6.8 $ | Oil & Gas Equipment & Services | Sells AI | — | Energy | 69.20 $ | +70.3 % | +76.6 % | +109.9 % | −7.8 % | +39.3 % | 92 | 87 | 7.0 % | 7.1 % | 1.26 | — | 384.6 | 9.0 | — | — | 0.94 | 23.5 | 25.8 % | 49.9 % | 7.2 % | 8.7 % | 4.1 % | — | 26.1 % | +98.7 % | 5 | 0.8 % | 43.2 % | 4.1 | 113.1 % | 23.8 % | 4.9 (8) | |
| IESC IES Holdings Inc | 08/07 | +416 % | 75 % | Stage 2 | A 78 | 6 of 9 | 6.7 $ | Engineering & Construction | Neutral | — | — | Industrials | 317.20 $ | +82.6 % | +77.9 % | +77.3 % | −4.7 % | +38.7 % | 92 | 79 | 7.0 % | 6.3 % | 1.78 | 15.7 | 208.3 | 1.7 | 5.5 | 19.1 | — | 18.9 | 11.5 % | 26.3 % | 11.4 % | 42.1 % | 16.5 % | 0.11 | 53.8 % | +16.9 % | 7 | 0.0 % | 0.0 % | 9.3 | 96.9 % | 9.0 % | — |
| MRX Marex Group plc | 08/12 | — | 47 % | Stage 2 | B 62 | 4 of 9 | 5.2 $ | Capital Markets | – | — | — | Financial Services | 73.30 $ | +74.6 % | +49.3 % | +121.7 % | −4.8 % | +9.0 % | 92 | 79 | 4.9 % | 4.7 % | -0.08 | 16.8 | 8.8 | 1.0 | 3.9 | — | — | 5.5 | 13.1 % | 70.1 % | 12.2 % | 29.1 % | 1.1 % | — | 3.7 % | +25.4 % | 8 | 0.9 % | 11.9 % | 4.2 | 75.2 % | 3.8 % | 4.3 (8) |
| PACS PACS Group, Inc. | — | — | 83 % | Stage 2 | B 72 | 7 of 9 | 6.5 $ | Medical Care Facilities | – | — | — | Healthcare | 42.10 $ | -2.7 % | +7.0 % | +274.9 % | −5.6 % | +40.1 % | 92 | 90 | 4.8 % | 4.7 % | -0.13 | — | 15.9 | 1.2 | — | 19.3 | 1.06 | 20.3 | 8.5 % | 17.3 % | 4.9 % | 27.1 % | 4.6 % | — | 18.3 % | +29.3 % | 5 | 0.0 % | 0.0 % | 4.2 | 30.5 % | 6.9 % | 4.8 (4) |
| HLIO Helios Technologies Inc | 08/03 | +15 % | 39 % | Stage 2 | B 67 | 9 of 9 | 2.3 $ | Specialty Industrial Machinery | – | — | — | Industrials | 68.00 $ | +67.8 % | +61.8 % | +27.6 % | −2.3 % | +39.2 % | 91 | 89 | 4.0 % | 3.8 % | 1.26 | — | 11.7 | 2.5 | — | 21.1 | 1.03 | 14.4 | 13.1 % | 33.6 % | 8.0 % | 6.7 % | 4.7 % | — | 61.9 % | +4.1 % | 3 | 0.7 % | 13.1 % | 7.8 | 101.8 % | 2.9 % | 4.4 (5) |
| TGTX TG Therapeutics Inc | 08/03 | +43 % | 45 % | Stage 2 | B 65 | 5 of 9 | 8.7 $ | Biotechnology | Neutral | — | Healthcare | 56.50 $ | +80.9 % | +79.3 % | +76.3 % | −6.5 % | +23.4 % | 90 | 92 | 5.0 % | 4.8 % | 1.66 | 20.3 | 24.6 | 10.9 | 15.2 | 498.6 | 1.61 | 59.7 | 17.0 % | 82.4 % | 55.2 % | 112.6 % | 7.3 % | 1.29 | 38.1 % | +87.3 % | 6 | 0.0 % | 0.0 % | 6.2 | 70.2 % | 28.5 % | 4.3 (9) | |
| INDV Indivior Pharmaceuticals, Inc. | 07/30 | +25 % | 37 % | Stage 2 | B 66 | 4 of 9 | 4.0 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | Healthcare | 35.70 $ | +11.4 % | +14.1 % | +55.4 % | −1.9 % | +37.3 % | 90 | 83 | 3.6 % | 3.6 % | 1.11 | 18.8 | 9.0 | 3.0 | 127.4 | — | — | 9.9 | 46.1 % | 85.7 % | 26.8 % | 12.2 % | 26.4 % | -3.49 | -12.0 % | +4.3 % | 4 | 0.0 % | 0.0 % | 3.6 | 107.5 % | 11.4 % | 4.7 (7) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Zanger's real strategy (not the widely circulated 'Liquid High Beta' variant). He buys institutional market leaders: explosive earnings growth (≥ 50%), top relative strength, high-priced liquid stocks near their highs, market cap up to $10 billion — and only enters on a volume breakout (≥ 300% of average) out of a base. This screener delivers the leader watchlist; the breakout itself is discretionary.
All scanners are recalculated daily across the entire stock universe — most recently on September 18, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 18 stocks pass this scanner's criteria (as of September 18, 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.
Related scanners
- Ben Bennett: Focus List
- Ben Bennett: Power Screen
- EPS & Revenue Power
- EPS Acceleration
- Growth Gems
- High Revenue Growth
- Jim Roppel: 20/20 Screen
- Joshua
- Martin Zweig: Growth with Reason
- Matt Caruso: Sales Leader
- Patrick Walker: 30% EPS Growth
- Patrick Walker: 40, 40 Screen
- Quality Growth
- Small Caps with Growth
- Ted Zhang: Super Stock Universe
- Thomas' Favorites
- Triple-Digit Revenue Growth
- William O'Neil (CAN SLIM)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.